Cohance Lifesciences Limited
Indian Pharmaceutical Exporter ยท Cardiovascular Specialist ยท $13.6M Total Trade ยท DGFT Verified
Cohance Lifesciences Limited is an Indian pharmaceutical exporter with a total trade value of $13.6M across 4 products in 4 therapeutic categories. Based on 278 verified export shipments from Indian Customs (DGFT) records, Cohance Lifesciences Limited is the #1 Indian exporter in 1 product including Itraconazole. Top exports include Isosorbide ($7.0M), Itraconazole ($3.5M), Spironolactone ($1.6M).
Cohance Lifesciences Limited โ Export Portfolio & Destination Treemap

Who is Cohance Lifesciences Limited? โ Company Overview & Market Position
Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited, was established in 1989 and is headquartered in Hyderabad, India. The company specializes in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (APIs), specialty chemicals, and formulated drugs. Its diverse product portfolio includes small molecule APIs, advanced intermediates, antibody drug conjugates, high-purity oligonucleotide building blocks, pellets, finished dosage forms, and specialty chemicals such as agrochemicals.
In May 2025, the company rebranded from Suven Pharmaceuticals Limited to Cohance Lifesciences Limited, reflecting its expanded capabilities and strategic direction. As of March 2026, Cohance Lifesciences Limited is a publicly listed entity on the National Stock Exchange of India (NSE) under the ticker symbol COHANCE and on the Bombay Stock Exchange (BSE) under the ticker symbol 543064. The company has a paid-up capital of โน3,432.79 crore and an authorized capital of โน3,499.94 crore.